The identification of new substrates of human DHRS7 by molecular modeling and in vitro testing.

No abstract is available for this paper.

• Publication year

  2017

• Venue

  International Journal of Biological Macromolecules

• Publication date

  2017-12-01

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1016/j.ijbiomac.2017.07.012PMID 28687384
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Current knowledge of the multifunctional 17β-hydroxysteroid dehydrogenase type 1 (HSD17B1).

  2016cited by this paper
• Human DHRS7, promising enzyme in metabolism of steroids and retinoids?

  2016cited by this paper
• Molecular and biochemical characterisation of human short-chain dehydrogenase/reductase member 3 (DHRS3).

  2015cited by this paper
• Towards a systematic analysis of human short-chain dehydrogenases/reductases (SDR): Ligand identification and structure-activity relationships.

  2015cited by this paper
• Human DCXR – another ‘moonlighting protein’ involved in sugar metabolism, carbonyl detoxification, cell adhesion and male fertility?

  2015cited by this paper
• Alcohol dehydrogenase, SDR and MDR structural stages, present update and altered era.

  2015cited by this paper
• A role for the dehydrogenase DHRS7 (SDR34C1) in prostate cancer

  2015cited by this paper
• Expression of Phosphofructokinase in Skeletal Muscle Is Influenced by Genetic Variation and Associated With Insulin Sensitivity

  2014cited by this paper
• Deeper insight into the reducing biotransformation of bupropion in the human liver.

  2014cited by this paper
• Purification and reconstitution of human membrane-bound DHRS7 (SDR34C1) from Sf9 cells.

  2014cited by this paper
• Biochemical properties of human dehydrogenase/reductase (SDR family) member 7.

  2014cited by this paper
• MicroRNA/gene profiling unveils early molecular changes and nuclear factor erythroid related factor 2 (NRF2) activation in a rat model recapitulating human hepatocellular carcinoma (HCC)

  2014cited by this paper
• Deciphering key features in protein structures with the new ENDscript server

  2014cited by this paper
• Leveraging structure for enzyme function prediction: methods, opportunities, and challenges.

  2014cited by this paper
• Role of carbonyl reducing enzymes in the phase I biotransformation of the non-steroidal anti-inflammatory drug nabumetone in vitro

  2013cited by this paper
• Human BDH2, an anti-apoptosis factor, is a novel poor prognostic factor for de novo cytogenetically normal acute myeloid leukemia

  2013cited by this paper
• Identification of benzoin obtained from calli of Styrax officinalis by HPLC

  2013cited by this paper
• MiRNA / gene profiling unveils early molecular changes and NRF 2 activation in a rat model recapitulating human HCC

  2013cited by this paper
• Jaguar: A high-performance quantum chemistry software program with strengths in life and materials sciences

  2013cited by this paper
• Co-Factor Binding Confers Substrate Specificity to Xylose Reductase from Debaryomyces hansenii

  2012cited by this paper
• HMDB 3.0—The Human Metabolome Database in 2013

  2012cited by this paper
• Classification of the short‐chain dehydrogenase/reductase superfamily using hidden Markov models

  2010cited by this paper
• Human carbonyl reductases.

  2010cited by this paper
• Structure-based design of 7-azaindole-pyrrolidine amides as inhibitors of 11β-hydroxysteroid dehydrogenase type I.

  2010cited by this paper
• Obesity and corticosteroids: 11beta-hydroxysteroid type 1 as a cause and therapeutic target in metabolic disease.

  2010cited by this paper
• The glucocorticoid-activating enzyme 11beta-hydroxysteroid dehydrogenase type 1 has broad substrate specificity: Physiological and toxicological considerations.

  2010cited by this paper
• LNCaP Atlas: Gene expression associated with in vivo progression to castration-recurrent prostate cancer

  2010cited by this paper
• In search for function of two human orphan SDR enzymes: hydroxysteroid dehydrogenase like 2 (HSDL2) and short-chain dehydrogenase/reductase-orphan (SDR-O).

  2009cited by this paper
• The human short-chain dehydrogenase/reductase (SDR) superfamily: a bioinformatics summary.

  2009cited by this paper
• 17beta-hydroxysteroid dehydrogenase 3 deficiency in a male pseudohermaphrodite.

  2008cited by this paper
• Characterization of human DHRS4: an inducible short-chain dehydrogenase/reductase enzyme with 3beta-hydroxysteroid dehydrogenase activity.

  2008cited by this paper
• Molecular docking for substrate identification: the short-chain dehydrogenases/reductases.

  2008cited by this paper
• Intracrine androgen metabolism in prostate cancer progression: mechanisms of castration resistance and therapeutic implications.

  2008cited by this paper
• NAD+-Dependent 15-Hydroxyprostaglandin Dehydrogenase Regulates Levels of Bioactive Lipids in Non–Small Cell Lung Cancer

  2008cited by this paper
• 17β-Hydroxysteroid dehydrogenase type 13 is a liver-specific lipid droplet-associated protein

  2008cited by this paper
• HPLC determination for prostaglandins from seaweed Gracilaria gigas

  2007cited by this paper
• RDH12, a retinol dehydrogenase causing Leber's congenital amaurosis, is also involved in steroid metabolism.

  2007cited by this paper
• Analyses of co‐operative transitions in Plasmodium falciparumβ‐ketoacyl acyl carrier protein reductase upon co‐factor and acyl carrier protein binding

  2006cited by this paper
• Hep27, a member of the short-chain dehydrogenase/reductase family, is an NADPH-dependent dicarbonyl reductase expressed in vascular endothelial tissue

  2006cited by this paper
• Multifunctionality of human 17beta-hydroxysteroid dehydrogenases.

  2006cited by this paper
• Multifunctionality of human 17β-hydroxysteroid dehydrogenases

  2006cited by this paper
• Structure and function of human 17beta-hydroxysteroid dehydrogenases.

  2006cited by this paper
• Integrated Modeling Program, Applied Chemical Theory (IMPACT)

  2005cited by this paper
• Inhibition of carboxylesterases by benzil (diphenylethane-1,2-dione) and heterocyclic analogues is dependent upon the aromaticity of the ring and the flexibility of the dione moiety.

  2005cited by this paper
• Human cytosolic 3alpha-hydroxysteroid dehydrogenases of the aldo-keto reductase superfamily display significant 3beta-hydroxysteroid dehydrogenase activity: implications for steroid hormone metabolism and action.

  2003cited by this paper
• Short-chain dehydrogenases/reductases (SDR): the 2002 update.

  2003cited by this paper
• Critical Residues for Structure and Catalysis in Short-chain Dehydrogenases/Reductases*

  2002cited by this paper
• Human pancreas protein 2 (PAN2) has a retinal reductase activity and is ubiquitously expressed in human tissues

  2002cited by this paper
• Short-chain dehydrogenases/reductases (SDRs).

  2002cited by this paper
• Molecular Characterization of Mammalian Dicarbonyl/l-Xylulose Reductase and Its Localization in Kidney*

  2002cited by this paper
• Critical residues for the specificity of cofactors and substrates in human estrogenic 17beta-hydroxysteroid dehydrogenase 1: variants designed from the three-dimensional structure of the enzyme.

  2001cited by this paper
• Novel enzymological profiles of human 11beta-hydroxysteroid dehydrogenase type 1.

  2001cited by this paper
• SDR Structure, Mechanism of Action, and Substrate Recognition

  2001cited by this paper
• Human 3α-hydroxysteroid dehydrogenase isoforms (AKR1C1–AKR1C4) of the aldo-keto reductase superfamily: functional plasticity and tissue distribution reveals roles in the inactivation and formation of male and female sex hormones

  2000cited by this paper
• Human 3alpha-hydroxysteroid dehydrogenase isoforms (AKR1C1-AKR1C4) of the aldo-keto reductase superfamily: functional plasticity and tissue distribution reveals roles in the inactivation and formation of male and female sex hormones.

  2000cited by this paper
• Crystal structure of the ternary complex of mouse lung carbonyl reductase at 1.8 A resolution: the structural origin of coenzyme specificity in the short-chain dehydrogenase/reductase family.

  1997cited by this paper
• Characterization of the substrate binding site in rat liver 3alpha-hydroxysteroid/dihydrodiol dehydrogenase. The roles of tryptophans in ligand binding and protein fluorescence.

  1996cited by this paper
• Verification of protein structures: Patterns of nonbonded atomic interactions

  1993cited by this paper

• DHRS7 Integrates NADP+/NADPH Redox Sensing with Inflammatory Lipid Signalling via the Oxoeicosanoid Pathway

  2025cites this paper
• The Potential Tumor-Suppressor DHRS7 Inversely Correlates with EGFR Expression in Prostate Cancer Cells and Tumor Samples

  2022cites this paper
• Cyclic immonium ion of lactyllysine reveals widespread lactylation in the human proteome

  2022cites this paper
• DHRS7 is an immune-related prognostic biomarker of KIRC and pan-cancer

  2022cites this paper
• Oral enzymatic detoxification system: Insights obtained from proteome analysis to understand its potential impact on aroma metabolization.

  2021cites this paper
• Discovery of Signature Cyclic Immonium Ion for Lactyllysine Reveals Widespread and Functional Lactylation on Non-histone Proteins

  2021cites this paper